North America Ai In Bioinformatics Market
حجم السوق بالمليار دولار أمريكي
CAGR : %
فترة التنبؤ |
2022 –2029 |
حجم السوق (السنة الأساسية) |
USD 1,000.00 Million |
حجم السوق (سنة التنبؤ) |
USD 19,677.40 Million |
CAGR |
|
Major Markets Players |
سوق المعلوماتية الحيوية للذكاء الاصطناعي في أمريكا الشمالية، حسب العرض (الخدمات والبرامج وغيرها)، النوع (التعلم الآلي، والتعلم العميق وغيرها)، المنتج والخدمات (خدمات المعلوماتية الحيوية، ومنصات المعلوماتية الحيوية، وأدوات إدارة المعرفة)، التطبيق ( علم الجينوم ، وعلم المعلومات الكيميائية وتصميم الأدوية، والبروتينات، وتسلسل الحمض النووي، وعلم الأحياء النظامي، والنسخ الجيني، واستخراج النصوص، والمصفوفات الدقيقة، وعلم الأيض وغيرها)، القطاع (التكنولوجيا الحيوية الطبية، والتكنولوجيا الحيوية الحيوانية، والتكنولوجيا الحيوية النباتية، والتكنولوجيا الحيوية البيئية، والتكنولوجيا الحيوية الشرعية وغيرها) - اتجاهات الصناعة وتوقعاتها حتى عام 2029.
تحليل وحجم سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية
أدى خفض تكلفة التسلسل الجيني إلى تعزيز الطلب في السوق. كما يساهم ارتفاع الإنفاق على الرعاية الصحية لتحسين الخدمات الصحية في نمو السوق. يركز اللاعبون الرئيسيون في السوق على إطلاق خدمات مختلفة والموافقات عليها خلال هذه الفترة الحاسمة. بالإضافة إلى ذلك، يساهم الطلب المتزايد على المعلوماتية الحيوية وزيادة تمويل القطاعين العام والخاص للمعلوماتية الحيوية أيضًا في زيادة الطلب على السوق.
يشهد سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية نموًا في عام التوقعات بسبب زيادة عدد اللاعبين في السوق وتوافر الخدمات المتقدمة. إلى جانب ذلك، يشارك المصنعون في أنشطة البحث والتطوير لإطلاق خدمات جديدة في السوق. تعمل التطورات المتزايدة في تكنولوجيا المعلوماتية الحيوية على تعزيز نمو السوق. ومع ذلك، فإن التكلفة العالية للأجهزة ومخاوف الأمن السيبراني في المعلوماتية الحيوية قد تعيق نمو سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية في فترة التوقعات.
إن التقدم التقني المتزايد والتحديث والمبادرات الاستراتيجية من قبل اللاعبين في السوق توفر فرصًا للسوق. ومع ذلك، فإن الافتقار إلى المتخصصين المهرة لأداء تكنولوجيا المعلومات الحيوية القائمة على الذكاء الاصطناعي والتحديات في تنفيذ تكنولوجيا المعلومات الحيوية في المختبرات السريرية تشكل تحديات رئيسية لنمو السوق.
تحلل شركة Data Bridge Market Research أن سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية من المتوقع أن تصل قيمته إلى 19,677.40 مليون دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب يبلغ 45.2% خلال الفترة المتوقعة. يغطي تقرير سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية أيضًا تحليل الأسعار وتحليل براءات الاختراع والتقدم التكنولوجي بشكل شامل.
تقرير القياس |
تفاصيل |
فترة التنبؤ |
2022 إلى 2029 |
سنة الأساس |
2021 |
سنوات تاريخية |
2020 (قابلة للتخصيص حتى 2019-2014) |
وحدات كمية |
الإيرادات بالملايين، الأحجام بالوحدات، التسعير بالدولار الأمريكي |
القطاعات المغطاة |
Offering (Services, Software, and Others), Type (Machine Learning, Deep Learning, and Others), Product and Services (Bioinformatics Services, Bioinformatics Platforms, and Knowledge Management Tools), Application (Genomics, Chemoinformatics & Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Text Mining, Microarrays, Metabolomics, and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others) |
Countries Covered |
U.S., Canada, and Mexico |
Market Players Covered |
JADBio & Gnosis Data Analysis, SOPHiA GENETICS, Biomax Informatics AG, DNASTAR, Ardigen, QIAGEN, Source BioScience., NeoGenomics Laboratories, Eurofins Scientific, Illumina, Inc., Thermo Fisher Scientific Inc., CelbridgeScience., Dassault Systemes, Fios Genomics, Insilico Medicine, Strand Life Sciences, Paige AI, Inc., SomaLogic Operating Co., Inc., and iNDX. Ai. Elucidata. |
Market Definition
The North America AI in bioinformatics market refers to the sector within the North American region where artificial intelligence (AI) technologies are applied in the field of bioinformatics. Bioinformatics involves the use of computational methods and techniques to analyze and interpret biological data, such as genomic sequences, protein structures, and large-scale biological experiments.
Bioinformatics combines computer programming, big data, and molecular biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
There are scores of branches of biology to specialize in, from genetics, toxicology, mycology, and radiobiology. And out of the many, bioinformatics is one of the intriguing fields that enables identifying, evaluating, storing, and retrieving biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data such as DNA sequencing, protein analysis, evolutionary genetics, and others.
North America AI in Bioinformatics Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Reduction in the Genetic Sequencing Cost
The strong demand for decreasing the cost of genomics and biomarker prediction has contributed to the creation of high-throughput genome sequencing, which often goes by next-generation sequencing (NGS). Thousands or millions of sequences in a single bioinformatics cycle are generated simultaneously. Dramatic upgrades to industrial NGS technologies have resulted in dramatic cutbacks in cost-per-base DNA sequencing. Thus, the main sequencing techniques have recently become the key research subject, with sample design optimization taking a secondary function.
With its parallel capacity to handle hundreds of millions of DNA templates, next-generation sequencing has greatly improved sequencing efficiency and reduced sequencing costs. Moreover, the cost of bioinformatics has decreased dramatically since the completion of the Human Genome Project, outpacing Moore's Law. Illumina has helped reduce the cost of bioinformatics instrumentation through continuous innovation, allowing the USD 1000 human genome.
- Growing Demand for Bioinformatics
As genomics-focused pharmacology continues to play a greater role in treating various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology.
NGS offers advantages in accuracy, sensitivity, and speed compared to traditional methods that have the potential to make a significant impact on the field of oncology. Because NGS can assess multiple genes in a single assay, the need to order multiple tests to identify the causative mutation is eliminated. AI in bioinformatics is important for data management in modern biology and medicine.
The increasing use of bioinformatics is driven by the explosion of biological data, the need for data integration and analysis, its applications in drug discovery and personalized medicine, its contribution to understanding complex biological systems, and its role in evolutionary biology and phylogenetic. Bioinformatics plays a significant role in advancing biological research, improving healthcare, and addressing various challenges in the life sciences.
Opportunity
- Rise in Healthcare Expenditure
The rise in healthcare expenditure by governments has been observed in many countries around the world. Healthcare expenditure has increased worldwide as people's disposable income in various countries increases. Moreover, to accomplish the population requirements, government bodies, and healthcare organizations are taking the initiative by accelerating healthcare expenditure. As populations age, there is an increased demand for healthcare services, including chronic disease management, long-term care, and end-of-life care. The elderly population tends to require more healthcare resources and services, leading to higher healthcare expenditures. There are some instances where many government organizations improved the solid funding for healthcare which boosted the healthcare market and it made a significant opportunity for North America AI in bioinformatics market.
Restraint/Challenge
- Cybersecurity Concerns in Bioinformatics
Bioinformatics datasets contain sensitive information, including genomic data, personal health information, and research data. If unauthorized individuals gain access to this data through breaches in cybersecurity defences, it can lead to privacy violations, identity theft, or misuse of the data.
However, the increasing computerization of DNA technology and biotechnology, more generally, raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems – such as the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-information systems in bioinformatics.
Post-COVID-19 Impact on North America AI in Bioinformatics Market
The AI in bioinformatics industry noted a decrease in demand due to the lockdown and COVID-19. Governmental laws, as manufacturing facilities and services were closed. COVID-19 created a major impact on various industries as almost every country has opted for the shutdown of every facility except the ones dealing in the essential goods segment. The government has taken some strict actions such as the shutdown of facilities and sale of non-essential goods, blocked international trade, and many more to prevent the spread of COVID-19. This boosted the North America AI in bioinformatics market, as the consumers were availing insurance to avoid huge capital payments at hospitals just in case of medical needs. Hence, COVID-19 impacted positively North America AI in the bioinformatics market.
Recent Developments
- In September 2022, Elucidata, a TechBio company, successfully raised USD 16 million in a Series A fundraising round. The funding was led by Eight Roads Ventures. The company plans to utilize the newly acquired capital to enhance product capabilities in translational drug research and related markets. Additionally, the funds will support the expansion of go-to-market initiatives and enable the company to grow its operations globally.
- In January 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd, a leading innovation-driven international healthcare group in China, and Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery and Development Company. The Company entered into a collaboration agreement to advance the discovery and development of drugs targeting several targets globally through AI technology. This has helped the company expand its market product portfolio and increase its global presence
North America AI in Bioinformatics Market Scope
North America AI in bioinformatics market is segmented on the basis of offering, type, product and services, application, and sector. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Offering
- Services
- Software
- Others
On the basis of offering, the North America AI in bioinformatics market is segmented into services, software and others.
Type
- Machine Learning
- Deep Learning
- Others
On the basis of type, North America AI in bioinformatics market is segmented into machine learning, deep learning, and others.
Products and Services
- Bioinformatics Services
- Bioinformatics Platforms
- Knowledge Management Tools
On the basis of product and services, the North America AI in bioinformatics market is segmented into bioinformatics services, bioinformatics platforms and knowledge management tools.
Application
- Genomics
- Chemoinformatics & Drug Design
- Proteomics
- DNA Sequencing
- System Biology
- Transcriptomics
- Text Mining
- Microarrays
- Metabolomics
- Others
On the basis of the application, the North America AI in bioinformatics market is segmented into genomics, chemoinformatics & drug design, proteomics, DNA sequencing, system biology, transcriptomics, text mining, microarrays, metabolomics and others.
Sector
- Medical Biotechnology
- Animal Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Forensic Biotechnology
- Others
On the basis of the sector, the North America AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others.
North America AI in Bioinformatics Market Regional Analysis/Insights
North America AI in bioinformatics market is analyzed, and market size insights and trends are provided by country, offering, type, products and services, application, and the sector as referenced above.
The countries covered in the North America AI in bioinformatics market report are U.S., Canada, and Mexico. U.S. dominates in the North America region due to the high demand for AI in bioinformatics devices. Additionally, The U.S. has a robust R&D ecosystem with a significant investment in scientific research. Leading universities and research institutions in the country have made substantial contributions to the field of bioinformatics, including the application of AI techniques.
كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغيرات في تنظيم السوق التي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية، وتحليل بورتر للقوى الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية في أمريكا الشمالية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية، وطرق التجارة أثناء تقديم تحليل توقعات لبيانات الدولة.
تحليل المشهد التنافسي وحصة سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية
يقدم المشهد التنافسي لسوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والمالية، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور في أمريكا الشمالية، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية.
بعض اللاعبين الرئيسيين العاملين في سوق الذكاء الاصطناعي في المعلوماتية الحيوية في أمريكا الشمالية هم JADBio & Gnosis Data Analysis و SOPHiA GENETICS و Biomax Informatics AG و DNASTAR و Ardigen و QIAGEN و Source BioScience. و NeoGenomics Laboratories و Eurofins Scientific و Illumina، Inc. و Thermo Fisher Scientific Inc. و CelbridgeScience. و Dassault Systemes Fios Genomics و Insilico Medicine و Strand Life Sciences و Paige AI، Inc. و SomaLogic Operating Co.، Inc. و iNDX. Ai. و Elucidata وغيرها.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA AI IN BIOINFORMATICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 OFFERING LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET SECTOR COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 NORTH AMERICA AI IN BIOINFORMATICS MARKET :MARKET OVERVIEW
5.1 DRIVERS
5.1.1 REDUCTION IN THE GENETIC SEQUENCING COST
5.1.2 GROWING DEMAND FOR BIOINFORMATICS
5.1.3 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTRUMENTATION
5.2.2 CYBERSECURITY CONCERNS IN BIOINFORMATICS
5.3 OPPORTUNITIES
5.3.1 RISE IN HEALTHCARE EXPENDITURE
5.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS
5.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM AI-BASED BIOINFORMATICS TECHNOLOGY
5.4.2 CHALLENGES OF IMPLEMENTING BIOINFORMATIC TECHNOLOGY IN THE CLINICAL LAB
6 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING
6.1 OVERVIEW
6.2 SERVICES
6.3 SOFTWARE
6.4 OTHERS
7 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 MACHINE LEARNING
7.3 DEEP LEARNING
7.4 OTHERS
8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES
8.1 OVERVIEW
8.2 BIOINFORMATICS SERVICES
8.2.1 DATA ANALYSIS
8.2.2 SEQUENCING SERVICES
8.2.3 DATABASE MANAGEMENT
8.2.4 OTHERS
8.3 BIOINFORMATICS PLATFORMS
8.3.1 SEQUENCE ANALYSIS PLATFORMS
8.3.2 SEQUENCE ALIGNMENT PLATFORMS
8.3.3 STRUCTURAL ANALYSIS PLATFORMS
8.3.4 SEQUENCE MANIPULATION PLATFORMS
8.3.5 OTHERS
8.4 KNOWLEDGE MANAGEMENT TOOLS
8.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
8.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENOMICS
9.3 CHEMOINFORMATICS & DRUG DESIGN
9.4 PROTEOMICS
9.5 DNA SEQUENCING
9.6 SYSTEM BIOLOGY
9.7 TRANSCRIPTOMICS
9.8 TEXT MINING
9.9 MICROARRAYS
9.1 METABOLOMICS
9.11 OTHERS
10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR
10.1 OVERVIEW
10.2 MEDICAL BIOTECHNOLOGY
10.3 ANIMAL BIOTECHNOLOGY
10.4 PLANT BIOTECHNOLOGY
10.5 ENVIRONMENTAL BIOTECHNOLOGY
10.6 FORENSIC BIOTECHNOLOGY
10.7 OTHERS
11 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY
11.1 U.S.
11.2 CANADA
11.3 MEXICO
12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 ILLUMINA, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 DASSAULT SYSTEMES
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 EUROFINS SCIENTIFIC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 THERMO FISHER SCIENTIFIC INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 QIAGEN
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 ARDIGEN
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 BIOMAX INFORMATICS AG
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 CELBRIDGESCIENCE.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 DNASTAR
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 ELUCIDATA
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 INDX. AI.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 INSILICO MEDICINE
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 JADBIO & GNOSIS DATA ANALYSIS
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 NEOGENOMICS LABORATORIES
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 PAIGE AI, INC.
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 SOMALOGIC OPERATING CO., INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 SOPHIA GENETICS
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENT
14.18 SOURCE BIOSCIENCE.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 BIOINFORMATICS COST PER SAMPLE
TABLE 2 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 11 U.S. AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 12 U.S. AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 13 U.S. AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 14 U.S. BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 15 U.S. BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 16 U.S. KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 17 U.S. AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 U.S. AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 19 CANADA AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 20 CANADA AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 21 CANADA AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 22 CANADA BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 23 CANADA BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 24 CANADA KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 25 CANADA AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 CANADA AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 27 MEXICO AI IN BIOINFORMATICS MARKET, BY OFFERING, 2020-2029 (USD MILLION)
TABLE 28 MEXICO AI IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 29 MEXICO AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 30 MEXICO BIOINFORMATICS SERVICES IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 31 MEXICO BIOINFORMATICS PLATFORMS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 32 MEXICO KNOWLEDGE MANAGEMENT TOOLS IN AI IN BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES, 2020-2029 (USD MILLION)
TABLE 33 MEXICO AI IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 34 MEXICO AI IN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA AI IN BIOINFORMATICS MARKET: NORTH AMERICA VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA AI IN BIOINFORMATICS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA AI IN BIOINFORMATICS MARKET: OFFERING LIFELINE CURVE
FIGURE 8 NORTH AMERICA AI IN BIOINFORMATICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA AI IN BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA AI IN BIOINFORMATICS MARKET: MARKET SECTOR COVERAGE GRID
FIGURE 11 NORTH AMERICA AI IN BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 13 THE REDUCTION IN THE GENETIC SEQUENCING COST AND GROWING DEMAND FOR BIOINFORMATICS ARE EXPECTED TO DRIVE THE NORTH AMERICA AI IN BIOINFORMATICS MARKET IN THE FORECAST PERIOD
FIGURE 14 THE SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AI IN BIOINFORMATICS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA AI IN BIOINFORMATICS MARKET
FIGURE 16 COST OF GENETIC SEQUENCING IN USD (YEAR WISE)
FIGURE 17 POSSIBLE IMPACT OF CYBER ATTACKS ON BIOINFORMATICS
FIGURE 18 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2021
FIGURE 19 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING, LIFELINE CURVE
FIGURE 22 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2021
FIGURE 23 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2021
FIGURE 27 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 30 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2021
FIGURE 31 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2021
FIGURE 35 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)
FIGURE 37 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE
FIGURE 38 NORTH AMERICA AI IN BIOINFORMATICS MARKET: SNAPSHOT (2021)
FIGURE 39 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021)
FIGURE 40 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 41 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 42 NORTH AMERICA AI IN BIOINFORMATICS MARKET: BY OFFERING (2022-2029)
FIGURE 43 NORTH AMERICA AI IN BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.